PME – May 2012. This issue PME talks to …
… Jane Griffiths
Company group chairman of Janssen EMEA tells PME why a focused product portfolio and expert staff are imperative to success
And we take a look at …
… Healthcare reform
The first article in the series from IMS looks at the impact of reforms on pharma and urges the industry to engage with governments through whatever means to ensure that its voice will be heard
… South Korea
One of the Asian Tiger economies, South Korea has maintained rapid growth levels, low state debt and a pharma industry that has achieved consistent double-digit growth for five years
… Innovation: improving the prospects for ATMPS in Europe
With large pharma companies still reluctant to develop cell, gene and tissue-based therapies, it is critical that regulators provide proactive support for sponsors
… Early phase strategic communication planning
Rob Kemsley, a Fellow of the Chartered Institute of Marketing and director of Syntropy Medica, explores why EPSCP has emerged as a major impetus in pharmaceutical communications development
View: May 2012 PME online
Also with this issue …
… Avoiding the Pharma Digital Trap
Armed with enthusiasm to conquer a new frontier, companies must not forget the key principles of marketing in the pursuit of a digital dream, cautions RAPP
